II. Epidemiology
- Fourth leading cause of Insomnia
- Family History of restless legs in 50-60%
- Incidence in adults: 6-10% (only 2 to 3% seek treatment)
- Incidence in adults over age 65 years: 10-28%
- More common in women
- Onset before age 18 in one third of patients
III. Risk Factors
- Family History of Restless Leg Syndrome (accounts for 50% of RLS patients)
- Iron Deficiency Anemia (especially if Serum Ferritin <50 ng/ml)
- Chronic Renal Failure (Chronic Kidney Disease)
- Antidepressant use (Akathisia)
- Pregnancy
- Neuropathy
IV. Pathophysiology: Possible etiologies
- Dopamine deficiency in Brainstem or spinal cord
- Endogenous Opiate deficiency
- Small fiber Peripheral Neuropathy
V. Causes
- Idiopathic in most cases
- Iron Deficiency Anemia
- Renal Dialysis
- Pregnancy (as high as 19%)
- Hypothyroidism
- Diabetes Mellitus
-
Electrolyte disturbance
- Decreased Serum Magnesium
- Decreased Serum Folate
- Leg varicosities
- May be relieved with sclerotherapy
- Drug-induced causes
- See Akathisia
- Selective Serotonin Reuptake Inhibitors (common)
- Antihistamines (e.g. Benadryl)
- Antipsychotics
- Antiemetics
- Lithium
- Tricyclic Antidepressants (e.g. Elavil)
- Treat with Propranolol 40 mg PO tid
- Substances
VI. Symptoms
- Timing
- Symptoms worsen in the afternoon, evening and bedtime
- Contrast with Periodic Limb Movement which occurs during sleep
- Overall urge to move legs due to uncomfortable leg Sensations (Akathisia)
- Severity
- Symptoms can cause very significant morbidity (to point of Suicidal Ideation)
- Palliative
- Movement (e.g. walking) temporarily relieves Sensation until sitting or lying back down again
- Provocative
- Prolonged period of inactivity (e.g. car travel)
- Prolonged sitting (e.g. classes or meetings)
- Lying down or sleeping
VII. Signs
- Periodic flexions
- Occur every 20-40 seconds during non-REM Sleep
VIII. Labs
- Serum Ferritin (<50 ng/ml associated with Restless Leg Syndrome)
- Serum Glucose
- Serum Creatinine
- Consider other lab testing to consider
IX. Differential Diagnosis
X. Diagnosis: Essential Features (4 criteria)
- Intense urge to move legs (typically asssociated with uncomfortable creeping or aching leg Sensations) AND
- Symptoms begin or worsen with rest or inactivity AND
- Symptoms are at least in part relieved with walking or Stretching AND
- Worse or limited to evening and overnight
XI. Management: General measures
- Discontinue provocative habits
- Discontinue Caffeine usage
- Tobacco Cessation
- Alcohol cessation
- Encourage relaxing bedtime routine
- Avoid vigorous Exercise 2 hours before bedtime
- Avoid sexual activity 2 hours before bedtime
- Adjust schedule to allow awakening later
- Correct Iron Deficiency Anemia
- Screen with Serum Ferritin in most if not all patients with Restless Leg Syndrome
- Consider Iron Supplementation for Serum Ferritin <75 mcg/L
- Local massage (leg massage)
- Moderate intensity Exercise (e.g. brisk walking) may also decrease symptoms longterm
- Cold compress application
- Consider adaptive changes at work or school
- Work at high desk with stool
- Sit in aisle seat on trips or meetings
- Consider sleep clinic referral for refractory symptoms
XII. Management: GABA Agents (preferred first line)
- First-line option for persistent restless legs
-
Gabapentin (Neurontin)
- Start: 300 mg orally at bedtime
- Increase: every 3-4 nights until symptoms controlled or at a maximum of 1800 mg
- Effective in RCT at 1800 mg/day (600 mg tid)
-
Pregabalin (Lyrica)
- Start 300 mg orally at bedtime
XIII. Management: Non-Ergotamine Dopamine Agonists (preferred second line)
- Preferred for frequent or nightly restless legs symptoms
- Quick onset of improved symptoms
- Risk of sedation, Nausea, Hallucinations and Compulsive Gambling and other behaviors
- Augmentation (worsening symptoms) occurs in 6-7% of patient per year
- Switch to GABA Agent (Gabapentin or Pregabalin) - see below
-
Pramipexole (Mirapex)
- Initial dose: 0.125 mg one tablet orally at bedtime
- Subsequent: Increase dose every third night until symptoms controlled or at a maximum of 4 tablets at bedtime
- See Mirapex for dosing strategy
-
Ropinirole (Requip)
- Initial dose: 0.25 mg orally at bedtime
- Subsequent: Increase dose every third night until symptoms controlled or at a maximum of 4 tablets at bedtime
- See Requip for dosing strategy
-
Rotigotine (Neupro) Transdermal
- Dopamine Agonist transdermal patch
- Indicated for moderate to severe symptoms refractory to Pramipexole or Ropinirole
- Dosing
- One patch applied daily to a new site
- Do not repeat the same site for 14 days
- Start at 1 mg/24 hours
- May increase weekly to a maximum of 3 mg/24 hours
XIV. Management: Other agents
-
Analgesics at bedtime
- Acetaminophen (Tylenol)
- NSAIDS (e.g. Ibuprofen)
- Nighttime Opioid Analgesics (e.g. Oxycodone 5-10 mg at bedtime) may also be effective
- Dopamine Agonists
- Ergotamine Dopamine Agonists
- Pergolide (Permax) 0.05 to 1 mg
- First dose at dinner
- Second dose one hour before bed
- Cabergoline (Dostinex)
- Initial dose: 0.5 mg PO at bedtime
- Pergolide (Permax) 0.05 to 1 mg
-
Benzodiazepines
- Not recommended
-
Alpha Adrenergic Agonists
- Clonidine 0.1 mg PO qhs
XV. Course
- Symptoms progress with age
XVI. Resources
- Restless Legs Syndrome Foundation
XVII. References
- (2017) Presc Lett 24(4):20-1
- (2000) Am Fam Physician 62:108-14 [PubMed]
- Bayard (2008) Am Fam Physician 78(2): 235-43 [PubMed]
- Clark (2001) J Am Board Fam Pract 14:368-74 [PubMed]
- Henning (1999) Sleep 22:970-99 [PubMed]
- Holder (2022) Am Fam Physician 105(4): 397-405 [PubMed]
- Paulson (2000) Geriatrics 55:35-48 [PubMed]
- Ramar (2013) Am Fam Physician 88(4): 231-8 [PubMed]